Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 25, 2017 - Issue 5
Submit an article Journal homepage
370
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Intravitreal Dexamethasone Implant for the Treatment of Macular Edema in Chronic Non-infectious Uveitis

Adrian C. TsangOttawa Hospital Research Institute, Ottawa, Ontario, Canada;Faculty of Medicine, University of Ottawa, Ottawa, Ontario, CanadaCorrespondence[email protected]
View further author information
, MD,
Gianni VirgiliDepartment of Ophthalmology, University of Florence, Florence, ItalyView further author information
, MD,
Maryam AbtahiOttawa Hospital Research Institute, Ottawa, Ontario, Canada;University of Ottawa Eye Institute, Ottawa, Ontario, CanadaView further author information
, MD &
Chloe C. GottliebOttawa Hospital Research Institute, Ottawa, Ontario, Canada;Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada;University of Ottawa Eye Institute, Ottawa, Ontario, CanadaView further author information
, MD
Pages 690-697 | Received 06 Dec 2015, Accepted 26 Feb 2016, Published online: 18 May 2016

REFERENCES

  • Tomkins-Netzer O, Taylor SRJ, Bar A, et al. Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis. Ophthalmology. 2014;21:1649–1654.
  • Lowder C, Belfort R Jr, Lightman S, et al.; Ozurdex HURON Study Group. Dexamethasone intravitreal implant for non-infectious intermediate or posterior uveitis. Arch Ophthalmol. 2011;129:545–553.
  • Okhravi N, Lightman S. Cystoid macular edema in uveitis. Ocul Immunol Inflamm. 2003;11:29–38.
  • Karim R, Sykakis E, Lightman S, et al. Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis. Clin Ophthalmol. 2013;7:1109–1144.
  • Sallam A, Taylor SR, Lightman S. Review and update of intraocular therapy in noninfectious uveitis. Curr Opin Ophthalmol. 2011;22:517–522.
  • Adan A, Pelegrin L, Rey A, et al. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients. Retina. 2013;33:1435–1440.
  • Kok H, Lau C, Maycock N, et al. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology. 2005;112:1916–1921.
  • van Kooij B, Rothova A, de Vries P. The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema. Ocul Immunol Inflamm. 2006;14:73–85.
  • Haller JA, Bandello F, Belfort R Jr, et al.; Ozurdex Geneva Study Group. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results. Ophthalmology. 2011;118:2453–2460.
  • Kuppermann BD, Blumenkranz MS, Haller JA, et al. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol. 2007;125:309–317.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
  • Zarranz-Ventura J, Carreño E, Johnston RL, et al. Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency. Am J Ophthalmol. 2014;158:1136–1145.e5.
  • Gallagher MJ, Yilmaz T, Cervantes-Castaneda RA, et al. The characteristic features of optical coherence tomography in posterior uveitis. Br J Ophthalmol. 2007;91:1680–1685.
  • Cao JH, Mulvahill M, Zhang L, et al. Dexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammation. Ophthalmology. 2014;121:1871–1876.
  • Lightman S, Jr RB, Naik RK, et al. Vision-related functioning outcomes of dexamethasone intravitreal implant in noninfectious intermediate or posterior uveitis. Invest Ophthalmol Vis Sci. 2013;54:4864–4870.
  • Miserocchi E, Modorati G, Pastore MR, et al. Dexamethasone intravitreal implant: an effective adjunctive treatment for recalcitrant noninfectious uveitis. Ophthalmologica. 2012;228:229–233.
  • Coca-Robinot J, Casco-Silva B, Armadá-Maresca F, et al. Accidental injections of dexamethasone intravitreal implant (Ozurdex) into the crystalline lens. Eur J Ophthalmol. 2014;24:633–636.
  • Berarducci A, Sian IS, Ling R. Inadvertent dexamethasone implant injection into the lens body management. Eur J Ophthalmol. 2014;24:620–622.
  • Rishi P, Mathur G, Rishi E. Fractured Ozurdex implant in the vitreous cavity. Indian J Ophthalmol. 2012;60:337–338.
  • Roy R, Hegde S. Split Ozurdex implant: a caution. Can J Ophthalmol. 2013;48:15–16.
  • Bhagat R, Zhang J, Farooq S, et al. Comparison of the release profile and pharmacokinetics of intact and fragmented dexamethasone intravitreal implants in rabbit eyes. J Ocul Pharmacol Ther. 2014;30:854–858.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.